As therapies become increasingly personalized, biomarker data can provide essential insights throughout the pharmaceutical pipeline — from determining disease prevalence to discovering optimal trial participants to honing physician outreach efforts to monitoring safety and efficacy. 

Join Andrew Goldberg, chief operating officer of HealthVerity, and Justin Niles, director, health informatics with Quest Diagnostics on June 12 at 12:00 p.m. ET to learn about the breadth and scope of biomarker data readily accessible through HealthVerity Marketplace. 

During this live webinar, we will explore Quest’s comprehensive biomarker and genetic testing technologies, methodologies and expertise. We will also discuss the variety of use cases for this powerful data type, including physician alerts to optimize provider education and outreach.

 Join this webinar to:

• Explore the breadth and scope of biomarker data available from Quest
  
  
• Learn how you can optimize go-to-market strategies with precision physician alerts using specific biomarker data
  
  
• Discover how you can sync far more insightful RWE with biomarkers in combination with other healthcare data types